Gilead’s HIV prospect lenacapavir hits FDA approval snag amid vial compatibility concerns fkansteiner Tue, 03/01/2022 – 10:48

FibroGen’s roxadustat safety mess draws SEC scrutiny as AstraZeneca-partnered anemia drug remains in limbo aliu Tue, 03/01/2022 – […]

The government needs to get tougher on public health and put more focus on interventions at the population […]

Appleby has picked up something of a poisoned chalice in predicting GP workforce requirements.1 His article appears in […]

Thousands of Russian doctors and other healthcare workers have signed an open letter to Vladimir Putin urging him […]

I spent many years as a medical teacher attempting to coach students in the art of empathy. Some […]

We, Russian doctors, nurses, and paramedics, strongly oppose the military actions carried out by Russian armed forces on […]

Sensor development project marks the fifth joint research effort between BioMed X with Boehringer Ingelheim

Johnson & Johnson, Legend’s CAR-T Carvykti enters myeloma ring with FDA nod aliu Mon, 02/28/2022 – 12:59

A clinical trial has shown that the immunotherapy drug pembrolizumab increased survival rates for head and neck cancer […]